A clinical trial involving researchers at University of Limerick, Ireland has demonstrated the potential benefits of new drugs in protecting kidney function in diabetes.
Dec 9, 2020
0
29
The mechanism by which statins increase the risk of type 2 diabetes has been investigated in a large-scale analysis from an international team led by researchers from UCL and the University of Glasgow, using information from ...
Sep 23, 2014
0
0
Scientists at Newcastle University believe a drug commonly prescribed for Type 2 diabetes could be routinely taken by Type 1 diabetic patients to slow the development or delay heart disease.
Aug 25, 2016
0
0
Type 1 diabetes is characterized by death and reduced function of β cells, which produce insulin. The presence of specific autoantibodies can identify individuals at risk of developing type 1 diabetes, and many of these ...
Feb 2, 2015
0
7
Although effective for the treatment of diabetes, exercise is sometimes difficult for overweight or elderly people. A new wearable medical device developed by Kumamoto University has been found to effect visceral fat loss ...
Nov 11, 2016
0
0
A phase II clinical trial testing the ability of the generic vaccine bacillus Calmette-Guérin (BCG) to reverse advanced type 1 diabetes has received approval from the U.S. Food and Drug Administration (FDA). The approval ...
Jun 7, 2015
1
470
People who suffer breathing and heart rate abnormalities, called obstructive sleep apnea, are likely to develop diabetes, and the risk increases if they have a hereditary proclivity.
Jan 5, 2015
0
57
(HealthDay)—Dentists are uniquely placed to identify patients with diabetes, and those with diabetes who are at risk for complications, according to an article published in the October issue of Clinical Diabetes.
Oct 31, 2014
0
0
Individuals with diabetes display a substantially increased risk of disease in left-sided heart valves compared to controls without diabetes, a comprehensive register study at the University of Gothenburg shows. The statistical ...
Jun 9, 2022
0
47
Preventing weight gain, obesity, and ultimately diabetes could be as simple as keeping a nuclear receptor from being activated in a small part of the brain, according to a new study by Yale School of Medicine researchers.
Aug 1, 2014
0
1
